Adrian Rawcliffe - Net Worth and Insider Trading
Adrian Rawcliffe Net Worth
The estimated net worth of Adrian Rawcliffe is at least $48,212 dollars as of 2024-04-28. Adrian Rawcliffe is the CEO of Adaptimmune Therapeutics PLC and owns about 44,848 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $48,212. Details can be seen in Adrian Rawcliffe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Adrian Rawcliffe has not made any transactions after 2024-01-17 and currently still holds the listed stock(s).
Transaction Summary of Adrian Rawcliffe
Adrian Rawcliffe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adrian Rawcliffe owns 2 companies in total, including Adaptimmune Therapeutics PLC (ADAP) , and WAVE Life Sciences Ltd (WVE) .
Click here to see the complete history of Adrian Rawcliffe’s form 4 insider trades.
Insider Ownership Summary of Adrian Rawcliffe
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2024-01-17 | Chief Financial Officer |
| WVE | WAVE Life Sciences Ltd | 2017-02-01 | director |
Adrian Rawcliffe Latest Holdings Summary
Adrian Rawcliffe currently owns a total of 1 stock. Adrian Rawcliffe owns 44,848 shares of Adaptimmune Therapeutics PLC (ADAP) as of January 17, 2024, with a value of $48,212.
Latest Holdings of Adrian Rawcliffe
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2024-01-17 | 44,848 | 1.08 | 48,212 |
Holding Weightings of Adrian Rawcliffe
Adrian Rawcliffe Form 4 Trading Tracker
According to the SEC Form 4 filings, Adrian Rawcliffe has made a total of 20 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the sale of 39,384 shares on January 17, 2024, which brought Adrian Rawcliffe around $27,569.
Insider Trading History of Adrian Rawcliffe
- 1
Adrian Rawcliffe Trading Performance
Adrian Rawcliffe Ownership Network
Ownership Network List of Adrian Rawcliffe
Ownership Network Relation of Adrian Rawcliffe
Adrian Rawcliffe Owned Company Details
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
Adrian Rawcliffe is the Chief Financial Officer of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Medical Officer Elliot Norry , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, Adrian Rawcliffe made 6 insider transaction in Adaptimmune Therapeutics PLC (ADAP) with a net sale of 115,184. Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 48,376 shares made by John Lunger , a net sale of 46,074 shares made by Bertrand William C Jr , and a net sale of 45,822 shares made by Elliot Norry .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315,048 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,048 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
Adrian Rawcliffe Mailing Address
Above is the net worth, insider trading, and ownership report for Adrian Rawcliffe. You might contact Adrian Rawcliffe via mailing address: 440 South Broad Street, Unit 1906, Philadelphia Pa 19146.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
